≥99% Purity KLOW Blend vial

KLOW Blend

Regenerative Peptide Blend

$135.00$101.25/vial with BOGO

USA basedcGMP facilityView COA

Quantity

Buy 1 Get 1 50% off · auto-appliedAdd 2+ items to cart — every second vial is 50% offOffer Ends 9/15

Same day / next business day dispatch

Free Shipping on orders over $200

Secure Checkout

Third-Party Tested

Money-Back Guarantee

PassedSterility & Endotoxins

PassedNet Content & Purity

Researchers also added

Bacteriostatic Water10mL

$13.00

GHK-Cu50mg

$65.00

BPC-15710mg

$65.00

About this compound

KLOW is a blend. Several peptides are combined and freeze-dried into a single 80 mg vial. Research on the individual ingredients covers collagen production, inflammation signaling, new blood vessel growth, and cell structure. Blends are supplied for researchers who want to test several pathways at once and compare the result against single compounds.

Four-peptide research blend (GHK-Cu, TB-500, BPC-157, KPV)

Formula: Mixture (GHK-Cu + TB-500 + BPC-157 + KPV)
Form: Lyophilized powder
Purity: ≥99% (HPLC verified)
Vial size: 80mg

Peptides Combined

GHK-Cu · TB-500 · BPC-157 · KPV

0mg

Total Peptide

Recovery & repair research blend

Multi

Pathway Coverage

Repair, angiogenesis, anti-inflammatory

Research Areas

Tendon, Muscle & Connective Tissue · Cell Migration & Angiogenesis · Skin, Collagen & Wound Models & more

How It Works

How KLOW Blend works

The pathways KLOW Blend acts on — and what each one does. Signalling pathways studied in preclinical models · illustrative.

Tissue Repair & Angiogenesis

BPC-157 + TB-500

In preclinical research, BPC-157 promotes skin, tendon, muscle and bone healing through growth-factor upregulation and angiogenic signaling. TB-500 (a thymosin β-4 fragment) is studied for promoting cell migration, reducing fibrosis, and enhancing regeneration across multiple injury models.

BPC-157: growth-factor upregulation and angiogenesis in repair models
TB-500: actin-binding effects on cell migration and regeneration
Both studied across tendon, muscle, cardiac and dermal injury models

Matrix & Collagen Support

GHK-Cu

GHK-Cu is a copper-binding tripeptide studied for enhancing collagen and elastin synthesis, supporting angiogenesis, and stimulating fibroblast migration — making it a frequent reference compound in extracellular-matrix and skin-repair research.

Enhances collagen and elastin synthesis in fibroblast models
Supports angiogenesis and fibroblast migration
Studied for extracellular-matrix remodeling and skin repair

Inflammation Modulation

KPV

KPV, the C-terminal tripeptide of α-MSH, inhibits NF-κB and MAP-kinase inflammatory signaling at nanomolar concentrations, reducing pro-inflammatory cytokine output — adding an anti-inflammatory axis to the blend's repair-focused components.

Inhibits NF-κB and MAP-kinase inflammatory signaling
Reduces TNF-α, IL-6 and IL-1β in research models
Adds an anti-inflammatory dimension to the repair blend

Uses & applications

What KLOW Blend is researched for

The main areas KLOW Blend is being studied for — and the study-reported figures behind them.

ORTHOPEDIC RESEARCH

Tendon, Muscle & Connective Tissue

BPC-157 and related repair peptides are studied in preclinical tendon, muscle and bone-healing models, with human validation still limited.

Sikiric et al. 1998

REGENERATIVE BIOLOGY

Cell Migration & Angiogenesis

BPC-157, TB-500 and GHK-Cu are frequently used together in in-vitro and ex-vivo systems to probe endothelial activity and matrix gene expression.

Ortho Sports Med. ReviewDERMATOLOGY

Skin, Collagen & Wound Models

GHK-Cu is a reference compound for collagen/elastin synthesis and fibroblast research; the blend is studied in dermal-repair contexts.

Therapeutic Peptides ReviewSPORTS MEDICINE

Recovery & Repair Pharmacology

Reviews of injectable peptide therapy examine the repair-focused peptide class, its mechanisms, and the current limits of the human evidence base.

Study-reported magnitudes

Representative figures from published research. Bars fill as you scroll.

BPC-157: Tendon / Muscle / Bone Healing (preclinical)Promoted
TB-500: Cell Migration & FibrosisEnhanced / Reduced
GHK-Cu: Collagen & Fibroblast ActivityStimulated
KPV: Pro-inflammatory CytokinesReduced

Figures are representative of published research findings and shown for reference.

Third-Party Verified

Independently tested. Verifiably pure.

Every batch of KLOW Blend is sent to an accredited independent laboratory before it ships. Here is what we screen for.

HPLC Purity AnalysisConfirms the peptide is ≥99% pure
Mass SpectrometryVerifies the exact molecular identity
Heavy Metals ScreeningLead, arsenic, cadmium & mercury — Pass
Endotoxins (LAL)Bacterial endotoxin levels — Pass
Sterility TestingNo microbial contamination — Pass
Net Peptide ContentActual peptide mass per vial verified

Compound Information

Full specification

Product Type	Four-peptide research blend
Component 1	GHK-Cu 50 mg — copper-binding tripeptide
Component 2	TB-500 10 mg — thymosin β-4 fragment
Component 3	BPC-157 10 mg — gastric pentadecapeptide
Component 4	KPV 10 mg — α-MSH C-terminal tripeptide
Total Peptide Content	80 mg per vial
Form	Lyophilized powder
Purity	≥99% (HPLC verified)
Testing	Third-party HPLC, Mass Spec, Endotoxin
Storage	-20°C for long-term stability
COA	Included with every order

FAQ

Common questions about KLOW Blend

KLOW is a four-peptide research blend combining GHK-Cu (50 mg), TB-500 (10 mg), BPC-157 (10 mg) and KPV (10 mg) — 80 mg of total peptide per vial. It groups together short peptides that are individually studied in tissue-repair, regeneration and anti-inflammatory research.

BPC-157 is studied for tendon, muscle and bone healing via growth-factor signaling; TB-500 (a thymosin β-4 fragment) for cell migration and reduced fibrosis; GHK-Cu for collagen synthesis and fibroblast activity; and KPV for NF-κB-mediated anti-inflammatory effects. Together they span repair, angiogenesis, matrix support and inflammation.

Each component acts through different mechanisms relevant to tissue repair. Combining them creates a single research model that touches multiple pathways at once — angiogenesis and growth-factor signaling (BPC-157, TB-500), extracellular-matrix support (GHK-Cu), and inflammation modulation (KPV).

No. None of the four components is an FDA-approved drug for tissue-repair indications. BPC-157 specifically is not approved by the FDA or EMA, and a 2023 FDA Category 2 designation restricts injectable compounding in the United States. Research-grade KLOW is supplied strictly for in vitro laboratory research.

BPC-157, TB-500 and GHK-Cu are used in in-vitro systems, ex-vivo tissue explants and animal models to study endpoints such as endothelial-cell activity in angiogenesis assays, fibroblast-associated matrix gene expression, cell migration and wound closure. KPV is used in inflammatory-signaling research.

Lyophilized KLOW should be stored at -20°C, protected from light and moisture, to preserve the integrity of all four peptides.

Published Literature

Peer-reviewed literature

Independent published research indexed from PubMed and peer-reviewed journals — not Zorva Lab claims.

[1] PubMedPUBMED · BPC 157's Effect on HealingView source →[2] PubMedPMC · Emerging Use of BPC-157 in Orthopaedic Sports MedicineView source →[3] PubMedPMC · Therapeutic Peptides in OrthopaedicsView source →[4] PubMedPUBMED · Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansView source →

For Research Use Only.

Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.

Back to catalog